Literature DB >> 23496198

Molecular testing in transfusion medicine.

Franz F Wagner1.   

Abstract

IMPORTANCE OF THE FIELD: Molecular blood group prediction, including mass scale donor genotyping, is becoming a routine part of transfusion medicine. AREAS COVERED IN THIS REVIEW: This review covers transfusion-related applications of the molecular prediction of antigens of red blood cells. Forensic and prenatal applications are not covered. The review is mainly based on the personal experience of the author in the field. A PubMed literature search without temporal limit was performed using the search item 'molecular testing transfusion' and complemented by 'related articles' searches of key publications. WHAT THE READER WILL GAIN: The readers will understand the general principles and specific problems arising from the use of molecular testing for blood group antigen prediction, get an overview of methods used at present, and learn which methods are suitable for which specific applications. TAKE HOME MESSAGE: At present, molecular methods complement serologic antigen determination and are an invaluable tool for specific diagnostic problems. Mass-scale molecular antigen prediction of blood donors is beginning to improve blood supply for specific patient groups.

Entities:  

Year:  2010        PMID: 23496198     DOI: 10.1517/17530059.2010.506509

Source DB:  PubMed          Journal:  Expert Opin Med Diagn        ISSN: 1753-0059


  4 in total

1.  Molecular typing for blood group antigens within 40 min by direct polymerase chain reaction from plasma or serum.

Authors:  Franz F Wagner; Willy A Flegel; Rita Bittner; Andrea Döscher
Journal:  Br J Haematol       Date:  2016-12-19       Impact factor: 6.998

2.  Implementing mass-scale red cell genotyping at a blood center.

Authors:  Willy A Flegel; Jerome L Gottschall; Gregory A Denomme
Journal:  Transfusion       Date:  2015-06-20       Impact factor: 3.157

3.  Integration of red cell genotyping into the blood supply chain: a population-based study.

Authors:  Willy A Flegel; Jerome L Gottschall; Gregory A Denomme
Journal:  Lancet Haematol       Date:  2015-07       Impact factor: 18.959

Review 4.  DEL in China: the D antigen among serologic RhD-negative individuals.

Authors:  Qinan Yin; Willy Albert Flegel
Journal:  J Transl Med       Date:  2021-10-20       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.